Steven Cohen's position in Viridian Therapeutics is currently worth $2.98 Million. That's 0.01% of their equity portfolio (633rd largest holding). The first Viridian Therapeutics trade was made in Q1 2021. Since then Steven Cohen bought shares five more times and sold shares on eight occasions. The investor's estimated purchase price is $3.5 Million, resulting in a loss of 15%.